Healthcare provider profile · identity verified

Daniel L Saddick, D.O.

Internal Medicine · ELMIRA, NY · NPI 1154785467

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	783	285
Amlodipine Besylate	Amlodipine Besylate	436	146
Lisinopril	Lisinopril	389	127
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	337	43
Losartan Potassium	Losartan Potassium	304	102
Metformin Hcl	Metformin Hcl	300	104
Glipizide	Glipizide	224	73
Omeprazole	Omeprazole	209	91
Levothyroxine Sodium	Levothyroxine Sodium	208	65
Rosuvastatin Calcium	Rosuvastatin Calcium	184	72
Atenolol	Atenolol	175	65
Simvastatin	Simvastatin	161	58
Hydrochlorothiazide	Hydrochlorothiazide	158	51
Albuterol Sulfate Hfa	Albuterol Sulfate	143	56
Tamsulosin Hcl	Tamsulosin Hcl	142	58
Gabapentin	Gabapentin	139	57
Metformin Hcl Er	Metformin Hcl	138	53
Terazosin Hcl	Terazosin Hcl	138	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	131	43
Alendronate Sodium	Alendronate Sodium	120	41
Furosemide	Furosemide	119	43
Jardiance	Empagliflozin	117	44
Metoprolol Tartrate	Metoprolol Tartrate	116	47
Potassium Chloride	Potassium Chloride	92	35
Meloxicam	Meloxicam	91	35
Lorazepam	Lorazepam	84	18
Breyna	Budesonide/Formoterol Fumarate	79	44
Pradaxa	Dabigatran Etexilate Mesylate	77	28
Humulin N	Insulin Nph Human Isophane	73	22
Trazodone Hcl	Trazodone Hcl	73	32
Carvedilol	Carvedilol	72	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	11
Pantoprazole Sodium	Pantoprazole Sodium	65	32
Allopurinol	Allopurinol	64	25
Triamcinolone Acetonide	Triamcinolone Acetonide	63	40
Clopidogrel	Clopidogrel Bisulfate	57	23
Ibuprofen	Ibuprofen	55	28
Finasteride	Finasteride	54	17
Clonazepam	Clonazepam	53	suppressed
Ezetimibe	Ezetimibe	52	20
Hydralazine Hcl	Hydralazine Hcl	49	17
Famotidine	Famotidine	46	18
Temazepam	Temazepam	46	suppressed
Alvesco	Ciclesonide	43	15
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	42	13
Fluoxetine Hcl	Fluoxetine Hcl	41	13
Tramadol Hcl	Tramadol Hcl	41	20
Pioglitazone Hcl	Pioglitazone Hcl	40	14
Buspirone Hcl	Buspirone Hcl	38	16
Lactulose	Lactulose	38	11
Humulin R	Insulin Regular, Human	37	11
Montelukast Sodium	Montelukast Sodium	37	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	12
Fenofibrate	Fenofibrate	35	suppressed
Colchicine	Colchicine	34	13
Ondansetron Hcl	Ondansetron Hcl	34	13
Pravastatin Sodium	Pravastatin Sodium	34	12
Alprazolam	Alprazolam	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	13
Duloxetine Hcl	Duloxetine Hcl	32	12
Estradiol	Estradiol	32	18
Azelastine Hcl	Azelastine Hcl	31	11
Hydrocortisone	Hydrocortisone	31	20
Prednisone	Prednisone	31	14
Clobetasol Propionate	Clobetasol Propionate	30	12
Cephalexin	Cephalexin	29	13
Naproxen	Naproxen	28	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	28	suppressed
Mirtazapine	Mirtazapine	27	12
Amoxicillin	Amoxicillin	26	21
Donepezil Hcl	Donepezil Hcl	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Ozempic	Semaglutide	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Spironolactone	Spironolactone	21	13
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Metoprolol Succinate	Metoprolol Succinate	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Eliquis	Apixaban	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	13	13
Glipizide Er	Glipizide	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Risperidone	Risperidone	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Digoxin	Digoxin	12	suppressed
Econazole Nitrate	Econazole Nitrate	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Metronidazole	Metronidazole	12	12
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Metformin Er Osmotic	Metformin Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Retin-A	Tretinoin	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error